Equitec Proprietary Markets Portfolio holdings
Top Buys
| 1 |
CDTX
Cidara Therapeutics
CDTX
|
+$4.65M |
| 2 |
HOLX
Hologic
HOLX
|
+$4.55M |
| 3 |
Warner Bros
WBD
|
+$935K |
| 4 |
DVAX
Dynavax Technologies
DVAX
|
+$374K |
| 5 |
RPTX
Repare Therapeutics
RPTX
|
+$238K |
Top Sells
| 1 |
K
Kellanova
K
|
+$4.25M |
| 2 |
ETNB
89bio
ETNB
|
+$1.91M |
| 3 |
ARIS
Aris Water Solutions
ARIS
|
+$673K |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$510K |
| 5 |
Electronic Arts
EA
|
+$404K |
Sector Composition
| 1 | Healthcare | 7.03% |
| 2 | Communication Services | 3.21% |
| 3 | Financials | 1.02% |
| 4 | Energy | 0.35% |
| 5 | Consumer Discretionary | 0.07% |
Similar funds
Equitec Proprietary Markets's Q4 2025 Portfolio in Review
As of Q4 2025, Equitec Proprietary Markets held 114 positions worth $174M, down 60% from $440M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Equitec Proprietary Markets withdrew a net $242M in Q4 2025, closing 31 positions and reducing 11 holdings. Its most notable exit was Kellanova, an estimated $4.25M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7% of assets, up from 0.54% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Equitec Proprietary Markets opened a new position in Cidara Therapeutics worth $6.36M.
- Equitec Proprietary Markets's largest Q4 2025 buy was Cidara Therapeutics: 28,787 shares worth $6.36M.
- Equitec Proprietary Markets added most to Western Midstream Partners in Q4 2025, an estimated $224K increase.
- Equitec Proprietary Markets's biggest Q4 2025 reduction was Electronic Arts, cutting an estimated $404K.
- Equitec Proprietary Markets fully exited Kellanova in Q4 2025, selling an estimated $4.25M.
- Equitec Proprietary Markets's ten largest holdings make up 83% of its $174M portfolio in Q4 2025.
- Equitec Proprietary Markets opened 38 new positions and closed 31 in Q4 2025.
- Equitec Proprietary Markets's portfolio value fell 60% quarter-over-quarter to $174M.
Based on Equitec Proprietary Markets's 13F filing for Q4 2025, filed 17 Feb 2026.